New legislation will attempt to shield the U.S. drug supply chain from counterfeiting and other illegal activities that can put patients at risk.
In a 30 to 0 vote, two FDA committees have opted to modify the Risk Evaluation and Mitigation Strategy (REMS) for extended-release opioids.
The Institute for Safe Medication Practices (ISMP) has issued new guidelines to reduce medication errors from IV compounding.
New research shows that it's ultimately cheaper to treat hepatitis C virus early, despite the upfront expense of direct-acting antivirals.
One expert discusses how best to manage your revenue amidst the complex codes, rules, and regulations.
The Pharmacy Practice News Report is brought to MedPage Today readers by our friends at Pharmacy Practice News, a McMahon Group title. Free registration required for some articles.
Preventing Supply Chain Crime: Pharmacy Practice News
Aucun commentaire:
Enregistrer un commentaire